Company: SYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009279
Chunk: 2

Company: Syra Health Corp
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 2
---
 981 
  
    Interest expense 
     (3,229) 
     (4,077)
  
    Total other income (expense) 
     1,069  
     (3,096)

    Net loss 
    $(472,265) 
    $(1,447,050)

    Weighted average common shares outstanding - basic and diluted 
     11,587,058  
     6,495,213 
  
    Net loss per common share - basic and diluted 
    $(0.04) 
    $(0.22)

See accompanying notes to condensed unaudited financial
statements.

F-2

SYRA HEALTH CORP.

STATEMENTS OF CHANGES IN
STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Capital  
    Deficit  
    (Deficit) 

    Class A  
    Convertible Class B  
    Additional  
       
    Total  Stockholders’ 

    Preferred Stock  
    Common Stock  
    Common Stock  
    Paid-in  
    Accumulated  
    Equity 

    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Capital  
    Deficit  
    (Deficit) 

    Balance, December 31, 2024 
     -  
    $-  
     8,979,204  
    $8,979  
     833,334  
    $833  
    $11,692,952  
    $(8,824,193) 
    $2,878,571 
  
    Warrants exercised for cash 
     -  
     -  
     23,125  
     23  
     -  
     -  
     14,777  
     -  
     14,800 
  
    Conversion of Class B common stock to Class A common stock 
     -  
     -  
     2,333,340  
     2,333  
     (233,334) 
     (233) 
     (2,100) 
     -  
     - 

    Class A common stock